e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Respiratory research in the Netherlands
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Advanced cell culture techniques and personalised medicine for cystic fibrosis
Jeffrey M. Beekman (Utrecht, Netherlands)
Source:
International Congress 2015 – Respiratory research in the Netherlands
Session:
Respiratory research in the Netherlands
Session type:
Symposium
Number:
1733
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jeffrey M. Beekman (Utrecht, Netherlands). Advanced cell culture techniques and personalised medicine for cystic fibrosis. International Congress 2015 – Respiratory research in the Netherlands
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Personalised medicine for cystic fibrosis: treating the basic defect
Source: Eur Respir Rev 2013; 22: 3-5
Year: 2013
Intestinal organoids as ex vivo models for personalised medicine in cystic fibrosis
Source: International Congress 2018 – Organoids and pluripotent stem cells
Year: 2018
The impact of personalised therapies on respiratory medicine
Source: Eur Respir Rev 2013; 22: 72-74
Year: 2013
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Source: Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021
Year: 2021
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Is cystic fibrosis the hemi-neglected part of respiratory medicine?
Source: Virtual Congress 2021 – CCC Thoracic oncology
Year: 2021
Genomically-guided therapies: a new era for cystic fibrosis
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020
Practical microbiology of cystic fibrosis lung disease
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
Personalised medicine in interstitial lung diseases
Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Year: 2018
A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021
Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Time to breathe: Progress in precision medicine in cystic fibrosis
Source: Short video discussion 2022
Year: 2022
Systems medicine advances in interstitial lung disease
Source: Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017
Year: 2017
Health-economic aspects of cystic fibrosis screening and therapy
Source: Eur Respir Monogr 2014; 64: 304-319
Year: 2014
Update on new treatments for cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020
Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Implementation of non-medical prescribing within the clinical cystic fibrosis setting
Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept